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To the Editor, approximately 10-12% of families these CYBB mutations are believed to arise de novo. 8 Female carriers of X-linked CGD exhibit a range of phenotypes, although in one series 37% 9 were completely asymptomatic and 52% had no features of CGD disease [2] . Common 10 manifestations in those who are symptomatic include recurrent oral ulceration, photosensitive 11 rashes and discoid lupus erythematosus (DLE) [2] [3] [4] [2] ) and indeed with extremely skewed lyonisation they can essentially develop the full 17 CGD syndrome [1] . Thus the carriage state can also confer a significant burden of disease.
18
We present a patient who was identified after his grandson was diagnosed with X-linked The brother and the three other daughters of the maternal grandfather of the index case 45 underwent genetic screening but all were negative for these mutations ( Figure 2D ).
Discussion
It has previously been reported that male patients with X-linked CGD can have small 50 populations of normal cells [6] , suggesting mutation in early embryogenesis, or early 51 reversion in some cell lines after the mutation arose in the oocytes. There has also been a case 52 report of an X-linked CGD patient's brother with Klinefelter's syndrome having carrier status 53 [7] , due to inheritance of both the mutated allele of CYBB and the normal allele. Case reports 54 of triple mosaic female carriers who had populations of neutrophils with two different 55 deletion mutations in CYBB and the normal variant have been described [8] , as has a late-56 onset somatic mutation in CYBB with subsequent mosaicism in haematopoietic cells in a 57 female [9] . However, this is the first report to our knowledge of a fertile male acting as a true 
Blood Saliva
Supplementary Methods NBT test. This was performed in accordance with published reports [1] . Briefly, 100 μl of EDTA whole blood was incubated with 100 μl of 0.2% NBT (Sigma) and 100 μl of 10 μg/ml phorbol 12-myristate 13-acetate (PMA) (Sigma) for 25 minutes at 37 o C, then 25 minutes at room temperature before mixing with 500 μl of 2% acetic acid and trace crystal violet; 10-μl aliquots were added to counting slides and examined at x40 magnification. DHR test. This was performed in accordance with published reports [2] . The PhagoBurst™ kit (Glycotope Biotechnology) was used on heparinised whole blood according to manufacturers' instructions and samples processed on a FACSCalibur flow cytometer. For analysis a DNA stain was used to identify live cells and then neutrophils were gated by forward and side scatter (Figure 2 ). Gp91 phox expression. This was determined in neutrophils (gated by forward and side scatter; Figure 2 ) via flow cytometry using 7D5 mAb against gp91 phox (IgG1, LifeSpan BioSciences) and a FITC-conjugated rabbit-anti-mouse IgG.
